074430 — Aminologics Co Balance Sheet
0.000.00%
- KR₩85bn
- KR₩52bn
- KR₩17bn
Annual balance sheet for Aminologics Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 25,383 | 25,663 | 29,238 | 28,499 | 35,382 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 4,833 | 6,517 | 5,710 | 8,560 | 4,838 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 35,325 | 38,679 | 43,569 | 45,249 | 46,517 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,585 | 2,120 | 2,826 | 2,630 | 3,090 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 60,129 | 65,243 | 55,582 | 57,668 | 56,789 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 6,047 | 5,381 | 3,429 | 2,668 | 4,342 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 6,571 | 5,849 | 4,178 | 3,257 | 5,094 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 53,558 | 59,393 | 51,404 | 54,411 | 51,695 |
Total Liabilities & Shareholders' Equity | 60,129 | 65,243 | 55,582 | 57,668 | 56,789 |
Total Common Shares Outstanding |